Glenview reportedly to meet top CVS brass, propose operational improvementsLarry Robbins, the founder of the hedge fund, has built a prominent position in CVS, which amounts to about $700 million of his $2.5 billion hedge fund, per a WSJ report. NACDS participates in White House meeting regarding respiratory illness seasonNACDS member pharmacies recently participated in a meeting with the White House Office of Pandemic Preparedness and Response Policy. Hikma launches foscarnet sodium injection The product is indicated for the treatment of CMV retinitis in patients with AIDS. CVS Health offers support as Hurricane Helene approaches CVS Pharmacy is reaching out to patients by text message, email and phone reminding them to refill and pick up prescriptions. AAM: Generic medicines increase patient access more than government negotiated price controls AAM is urging Congress and regulators to stop patent abuses and streamline approvals. Sandoz report weighs in on how to solve America’s drug shortage problem For the last six years, 84% of the medicines in shortage have been generics. FDA gives Lupin approval for bumetanide injection Bumetanide injection is indicated for the treatment of edema associated with congestive heart failure, hepatic disease and renal disease. Biosimilars Council urges House to pass patent thicket legislation S. 150 passed the Senate and was placed on the House of Representatives' suspension calendar. Body, heal thyself A focus on wellness, personalized treatments and clean ingredients has fueled interest in homeopathic products. FDA approves Roche’s Ocrevus Zunovo with Halozyme’s Enhanze drug delivery technology Ocrevus Zunovo with Halozyme's Enhanze drug delivery technology is used for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis. First Previous 16 17 18 19 20 Next Last
